which glp 1 is best for kidney disease What the GLP-1 (Glucagon-like peptide-1) receptor agonist patients with Chronic (CKD)? The cardiovascular and renal effects
Description
Clinically studied for greater weight loss than GLP-1 alone
The FDA has approved glucagon-like peptide-1 (GLP-1) receptor agonists such as Liraglutide, Semaglutide, and the GLP-1/gastric inhibitory polypeptide (GIP) dual agonist Tirzepatide for the treatment of obesity
Meisha K
A more mindful, wellness-forward approach to GLP-1 use
